MUC2 and mucinous adenocarcinoma: Mucinous adenocarcinoma, accounting for 10–15% of CRCs, is characterized by distinct molecular and clinicopathological features, including MUC2 overexpression, microsatellite instability (MSI), and multiple metastases [16].